244 related articles for article (PubMed ID: 22584732)
1. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors.
Desai K; Mao JJ; Su I; Demichele A; Li Q; Xie SX; Gehrman PR
Support Care Cancer; 2013 Jan; 21(1):43-51. PubMed ID: 22584732
[TBL] [Abstract][Full Text] [Related]
2. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors.
Hong D; Bi L; Zhou J; Tong Y; Zhao Q; Chen J; Lu X
Oncotarget; 2017 Jun; 8(25):40558-40567. PubMed ID: 28489562
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.
Mao H; Bao T; Shen X; Li Q; Seluzicki C; Im EO; Mao JJ
Eur J Cancer; 2018 Sep; 101():47-54. PubMed ID: 30014974
[TBL] [Abstract][Full Text] [Related]
4. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
Su HI; Sammel MD; Springer E; Freeman EW; DeMichele A; Mao JJ
Breast Cancer Res Treat; 2010 Nov; 124(1):205-11. PubMed ID: 20182796
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors.
Romero SAD; Su HI; Satagopan J; Li QS; Seluzicki CM; Dries A; DeMichele AM; Mao JJ
Breast; 2020 Feb; 49():48-54. PubMed ID: 31678641
[TBL] [Abstract][Full Text] [Related]
6. Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
Bauml J; Chen L; Chen J; Boyer J; Kalos M; Li SQ; DeMichele A; Mao JJ
Breast Cancer Res; 2015 Jun; 17(1):89. PubMed ID: 26126656
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
[TBL] [Abstract][Full Text] [Related]
8. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.
Mao JJ; Stricker C; Bruner D; Xie S; Bowman MA; Farrar JT; Greene BT; DeMichele A
Cancer; 2009 Aug; 115(16):3631-9. PubMed ID: 19517460
[TBL] [Abstract][Full Text] [Related]
9. Severe hot flashes are associated with chronic insomnia.
Ohayon MM
Arch Intern Med; 2006 Jun; 166(12):1262-8. PubMed ID: 16801508
[TBL] [Abstract][Full Text] [Related]
10. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
Castel LD; Hartmann KE; Mayer IA; Saville BR; Alvarez J; Boomershine CS; Abramson VG; Chakravarthy AB; Friedman DL; Cella DF
Cancer; 2013 Jul; 119(13):2375-82. PubMed ID: 23575918
[TBL] [Abstract][Full Text] [Related]
11. Mental health impacts among health workers during COVID-19 in a low resource setting: a cross-sectional survey from Nepal.
Khanal P; Devkota N; Dahal M; Paudel K; Joshi D
Global Health; 2020 Sep; 16(1):89. PubMed ID: 32977818
[TBL] [Abstract][Full Text] [Related]
12. Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome.
Chedraui P; San Miguel G; Villacreses D; Dominguez A; Jaramillo W; Escobar GS; Pérez-López FR; Genazzani AR; Simoncini T;
Maturitas; 2013 Feb; 74(2):154-9. PubMed ID: 23176759
[TBL] [Abstract][Full Text] [Related]
13. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
14. Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04).
Fontein DB; Charehbili A; Nortier JW; Putter H; Kranenbarg EM; Kroep JR; Linn SC; van de Velde CJ
Eur J Surg Oncol; 2017 Apr; 43(4):619-624. PubMed ID: 28017458
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with psychological distress among patients with breast cancer during the COVID-19 pandemic: a cross-sectional study in Wuhan, China.
Chen X; Wang L; Liu L; Jiang M; Wang W; Zhou X; Shao J
Support Care Cancer; 2021 Aug; 29(8):4773-4782. PubMed ID: 33527226
[TBL] [Abstract][Full Text] [Related]
16. The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study.
Bryl K; Chimonas S; Li X; Li SQ; Mao JJ
Breast Cancer Res Treat; 2023 Jul; 200(2):257-264. PubMed ID: 37226019
[TBL] [Abstract][Full Text] [Related]
17. Hot flashes, insomnia, and the reproductive stages: a cross-sectional observation of women from the EPISONO study.
Hachul H; Castro LS; Bezerra AG; Pires GN; Poyares D; Andersen ML; Bittencourt LR; Tufik S
J Clin Sleep Med; 2021 Nov; 17(11):2257-2267. PubMed ID: 34170233
[TBL] [Abstract][Full Text] [Related]
18. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
Mao JJ; Su HI; Feng R; Donelson ML; Aplenc R; Rebbeck TR; Stanczyk F; DeMichele A
Breast Cancer Res; 2011 Jan; 13(1):R8. PubMed ID: 21251330
[TBL] [Abstract][Full Text] [Related]
19. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
Chim K; Xie SX; Stricker CT; Li QS; Gross R; Farrar JT; DeMichele A; Mao JJ
BMC Cancer; 2013 Sep; 13():401. PubMed ID: 24004677
[TBL] [Abstract][Full Text] [Related]
20. Factors relating to insomnia during the menopausal transition as evaluated by the Insomnia Severity Index.
Arakane M; Castillo C; Rosero MF; Peñafiel R; Pérez-López FR; Chedraui P
Maturitas; 2011 Jun; 69(2):157-61. PubMed ID: 21444163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
